Coligation of paired immunoglobulin-like receptor B (PIR-B) with B cell antigen receptor (BCR) blocks antigen-induced B cell activation. This inhibition is mediated in part by recruitment of SHP-1 and SHP-2 to the phosphorylated ITIMs in the cytoplasmic domain of PIR-B; however the molecular target(s) of these phosphatases remain elusive. Here we show that PIR-B ligation inhibits the BCR-induced tyrosine phosphorylation of Iga/Igb, Syk, Btk and phospholipase C (PLC)-g2. Overexpression of a catalytically inactive form of SHP-1 prevents the PIR-B-mediated inhibition of tyrosine phosphorylation of Syk, Btk, and PLC-g2. Dephosphorylation of Syk and Btk mediated by SHP-1 leads to a decrease of their kinase activity, which in turn inhibits tyrosine phosphorylation of PLC-g2. Furthermore, we de®ne a requirement for Lyn in mediating tyrosine phosphorylation of PIR-B. Based on these results, we propose a model of PIR-B-mediated inhibitory signaling in which coligation of PIR-B and BCR results in phosphorylation of ITIMs by Lyn, subsequent recruitment of SHP-1, and a resulting inhibition of the BCR-induced inositol 1,4,5-trisphosphate generation by dephosphorylation of Syk and Btk.
Introduction
Antigen-mediated clustering of B cell antigen receptor (BCR) induces a transient protein tyrosine kinase (PTK) activity that activates several biochemical pathways and culminates in proliferation, differentiation, or apoptosis. Three distinct types of PTKs have been found to be activated upon BCR engagement: Src-family PTKs (including Lyn, Fyn, and Blk), Syk, and Btk. A multistep model for BCR signaling has been proposed in which Lyn is the ®rst to be activated after BCR stimulation and phosphorylates the tyrosine residues in the ITAM sequences (for immunoreceptor tyrosine-based activation motif) within Iga and Igb subunits. The phosphorylated ITAMs recruit Syk, which becomes phosphorylated and activated. Critical downstream signaling events include the activation of phospholipase C (PLC)-g2, which is mediated by Syk and Btk. The activated PLC-g2 converts phosphatidylinositol 4,5-bisphosphate into the two second messengers diacylglycerol (DG) and inositol 1,4,5-trisphosphate (IP 3 ) which results in activation of protein kinase C and increases in [Ca 2+ ] i , respectively (for reviews see references: DeFranco, 1997; Kurosaki, 1997; Pleiman et al., 1994; Reth and Wienands, 1997) .
B cells express paired immunoglobulin-like receptor B (PIR-B), an integral membrane protein that contains six Ig-like domains in the extracellular portion and four potential ITIMs (for immunoreceptor tyrosinebased inhibitory motifs) in the cytoplasmic domain (Hayami et al., 1997; Kubagawa et al., 1997) . We and others have recently demonstrated that PIR-B inhibits the BCR signaling in a phosphotyrosine-dependent manner and that, among four potential ITIMs, Tyr 771 and Tyr 801 are critical for mediating inhibitory signals ( Figure 1 ) (BleÂ ry et al., 1998; Maeda et al., 1998) . Although the ligand for PIR-B is still unknown, PIR-B is inert until co-ligated to BCR at which time it undergoes tyrosine phosphorylation of ITIMs in its cytoplasmic domain. This phosphorylation leads to the recruitment of SHP-1 and SHP-2, which are responsible for the inhibition of calcium mobilization in the stimulated B cells.
In this report, we have examined the molecular mechanism underlying PIR-B-mediated inhibition of B cell activation. We ®rst provide genetic evidence that Lyn is speci®cally required for tyrosine phosphorylation of critical ITIMs in the PIR-B cytoplasmic domain and its association with SHP-1 and SHP-2. The associated tyrosine phosphatases mediate dephosphorylation of Syk, Btk, and PLC-g2. Since activation of Syk and Btk is essential for PLC-g2 activation upon BCR engagement, our results suggest that downregulation of Syk and Btk acitivity by SHP-1 and SHP-2 is a potential mechanism for inhibition of IP 3 generation and calcium mobilization by PIR-B.
in Figure 1a ), phosphorylation of both Tyr  771 and Tyr   801 is involved in PIR-B-mediated inhibitory signal presumably through recruitment of tyrosine phosphatases SHP-1 and SHP-2 (BleÂ ry et Maeda et al., 1998 ).
To formally demonstrate that the PIR-B cytoplasmic region containing doubly phosphorylated Tyr 771 and Tyr 801 is indeed the recruitment site for SHP-1 and SHP-2 in vivo, we transfected FcgRIIB-PIR-B mutant in which all remaining Tyr residues in the PIR-B cytoplasmic domain are changed to Phe (Y690, 719, 747F), into the FcgRIIB-negative B cell mutant cell line (A20 IIA1.6) ( Figure 1a) . Cell surface expression level of this chimeric receptor was checked by¯ow cytometric analysis using anti-mouse FcgRIIB mAb, 2.4G2 (shown in Figure 1b inset box). As demonstrated in Figure 1b and c, coligation of FcgRIIB-PIR-B(Y690, 719, 747F) and BCR inhibited the calcium mobilization and recruited SHP-1 and SHP-2. Conversely, FcgRIIB-PIR-B(Y771, 810F) neither inhibited the BCR-induced calcium mobilization nor recruited SHP-1 and SHP-2. Three species of SHP-2 which migrated distinctly (right panel in Figure 1c ) are presumably due to post-translational and/ or post-transcriptional modi®cations of SHP-2, because three SHP-2 species similarly observed in DT40 B cells could not be detected after targeted deletion of the SHP-2 gene (data not shown).
Lyn is required for tyrosine phosphorylation of PIR-B at Tyr 771 and Tyr
801
The above observations prompted us to examine the responsible PTK(s) for FcgRIIB-PIR-B(Y690, 719, 747F) tyrosine phosphorylation upon its coligation with BCR. For this purpose, we trasnfected FcgRIIB-PIR-B(Y690, 719, 747F) into Lyn-or Syk-de®cient mutant DT40 cells . After obtaining transformants expressing similar level of FcgRIIB-PIR-B(Y690, 719, 747F), DT40 cells deficient in Lyn or Syk were stimulated by BCR crosslinking alone or coligation of BCR and the inhibitory receptor ( Figure 2 ). Consistent with our previous results using mouse A20 B cells (Maeda et al., 1998) 
PIR-B inhibits PLC-g2 activation
IP 3 generation by PLC-g2 activation is essential for BCR-induced calcium mobilization from intracellular pools (Sugawara et al., 1997; Takata et al., 1995) . Then, Ca 2+ enters the cytoplasm by a process termed capacitative Ca 2+ entry, by which the depletion of intracellular stores by IP 3 activates calcium in¯ux across the plasma membrane (Putney and Bird, 1993) . Thus, inhibition of the BCR-induced calcium mobilization by PIR-B could be accounted for by two possible mechanisms: inhibition of the BCR-induced IP 3 generation or inhibition of capacitative Ca 2+ entry process. To distinguish these two possibilities, we determined IP 3 generation by BCR cross-linking alone or coligation of BCR and FcgRIIB-PIR-B. As shown in Figure 3a , BCR cross-linking alone generated IP 3 while this generation was abrogated by coligation of the inhibitory receptor and BCR. Consistent with this result, BCR-induced tyrosine phosphorylation of PLCg2 was profoundly inhibited by its coligation with FcgRIIB-PIR-B (Figure 3b ). Thus, we conclude that coligation of BCR and FcgRIIB-PIR-B inhibits PLCg2 tyrosine phosphorylation, thereby leading to inhibition of IP 3 generation. Early activation of PTKs, particularly Syk and Btk, is involved in PLC-g2 activation upon BCR engagement (Kurosaki, 1997) . Therefore, data presented in Figure 3 could be explained by PIR-B-mediated dephosphorylation of PLC-g2 and/or its upstream PTKs, Syk and Btk. To examine these possibilities, the status of tyrosine phosphorylation of Syk and Btk was determined by immunoprecipitation followed by Western blotting with antiphosphotyrosine mAb. As shown in Figure 4a and b, the BCR-induced tyrosine phosphorylation of Syk and Btk was dramatically inhibited by coligation of BCR and FcgRIIB-PIR-B. Moreover, dephosphorylation of Syk and Btk by FcgRIIB-PIR-B resulted in inhibition of their kinase activity, as assessed by in vitro kinase assay. As reported previously (Burkhardt et al., 1991; Yamanashi et al., 1992) , Lyn is activated about 1.5-fold upon BCR stimulation alone (Figure 4c ). In contrast to inhibition of Syk and Btk, coligation of the BCR and FcgRIIB-PIR-B did not inhibit the tyrosine phosphorylation and kinase activity of Lyn. Since binding of Syk to phosphorylated Iga/Igb is essential for participation of Syk in downstream signaling events such as PLC-g2 activation (DeFranco, 1997; Kurosaki, 1997; Pleiman et al., 1994; Reth and Wienands, 1997) , we also determined whether BCR-induced tyrosine phosphorylation of Iga and Igb is inhibited by its coligation with FcgRIIB-PIR-B. As shown in Figure  4d , coligation of the BCR and FcgRIIB-PIR-B inhibited phosphorylation of both Iga and Igb. Thus, these observations indicate that ligation of FcgRIIB-PIR-B inhibits BCR-induced tyrosine phosphorylation of four critical signaling molecules: Iga/Igb, Syk, Btk, and PLC-g2. Furthermore, dephosphorylation of Syk and Btk leads to inhibition of their kinase activity.
To investigate whether the FcgRIIB-PIR-B-mediated inhibition of tyrosine phosphorylation of signaling molecules could be attributed to SHP-1, we employed vaccinia virus-driven overexpression system of SHP-1 ( Figure 5) . Expression of the catalytically inactive SHP-1-C453S, but not wild type SHP-1, signi®cantly reversed the FcgRIIB-PIR-B-mediated inhibition of tyrosine phosphorylation of Syk, Btk, and PLC-g2 ( Figure 6 ). Moreover, kinase activity of Syk and Btk was also restored by expression of SHP-1-C453S. In contrast, inhibition of Iga tyrosine phosphorylation was less reversed than Syk and Btk. These results demonstrate that FcgRIIB-PIR-B ligation interrupts tyrosine phosphorylation of Syk, Btk, and PLC-g2 via an SHP-1 dependent mechanism.
Discussion
Recent studies have shown that among the ®ve tyrosine residues in the PIR-B cytoplasmic domain, phosphorylation of Tyr 771 and Tyr 801 is required for its inhibitory mechanism (BleÂ ry et al., 1998; Maeda et al., 1998 Data presented here demonstrate that Lyn, but not Syk, is required for PIR-B ITIM tyrosine phosphorylation in DT40 B cells. Because Lyn is dominantly expressed among Src-family PTKs particularly in DT40 cells , it is likely that other Srcfamily PTKs such as Fyn and Blk are also capable of phosphorylating PIR-B ITIMs. Since Lyn is apparently involved in activating BCR signal by phosphorylating ITAMs in Iga/Igb and Syk (DeFranco, 1997; Kurosaki, 1997; Pleiman et al., 1994; Reth and Wienands, 1997) , our results support the contention that Lyn has both positive and negative roles in B cell activation (DeFranco, 1997; Kurosaki, 1997) . The negative role of Lyn appears to be mediated in part by PIR-B as well as FcgRIIB and CD22 (Chan et al., 1997; Nishizumi et al., 1998; O'Rourke et al., 1997; Wang et al., 1996) . Slight PIR-B tyrosine phosphorylation by BCR alone, although less ecient than occurring after coligation of BCR and PIR-B (Figure  2 ), might provide insights into the mechanism by which PIR-B modulates B cell activation in vivo. Assuming that a small fraction of SHP-1 or SHP-2 is recruited to the slightly phosphorylated PIR-B by BCR ligation alone, a small portion of the inhibitory function of PIR-B might not necessarily require coligation of BCR and PIR-B. Nevertheless, it is clear that coligation of BCR and PIR-B inhibits BCR activation more dramatically.
Here we explored the molecular mechanisms of PIR-B-mediated inhibition of B cell activation. In contrast to FcgRIIB inhibition (Gupta et al., 1997; Hippen et al., 1997; Nadler et al., 1997; Ono et al., 1997), BCRinduced activation of the upstream tyrosine kinases Syk and Btk, as well as many other substrates were drastically inhibited by its coligation with PIR-B, strengthening our previous conclusion that PIR-B inhibits the B cell activation by utilizing a dierent inhibitory mechanism than FcgRIIB. Thus, PIR-B apparently belongs to a class of KIR-type inhibitory receptors (Ono et al., 1997) . Indeed, similar to PIR-Bmediated inhibition, coligation of FcR and KIR inhibits tyrosine phosphorylation of many of substrate phosphorylated by stimulation of the FcR alone (Binstadt et al., 1996) .
Since IP 3 generation and its binding to IP 3 receptors are essential for the BCR-induced calcium mobilization from intracellular pools (Sugawara et al., 1997; Takata et al., 1995) , our data indicate that PIR-B aborts the initial release of Ca 2+ from the intracellular pools by inhibiting IP 3 generation through down-regulation of PLC-g2. As SHP-1 and SHP-2 are required for PIR-B- , another slower migrating Syk species was observed upon BCR stimulation. Immunoprecipitates were divided, and half of them were used for Western blotting with mAb 4G10 (upper panel). After the ®lter was stripped, the same blot was reprobed (lower panel). The remaining half were used for in vitro kinase assay (middle panel in a ± c). Reaction samples in Syk were separated by 12.5% SDS ± PAGE gel, transferred and immunoblotted with anti-phosphotyrosine mAb 4G10. For Btk and Lyn, samples were electrophoresed by 8% SDS ± PAGE gel mediated inhibition of calcium mobilization (Maeda et al., 1998) , the simplest interpretation for inhibition of PLC-g2 tyrosine phosphorylation is that PLC-g2 serves as a direct substrate of SHP-1 and SHP-2. Assuming that PLC-g2 is a sole substrate of SHP-1 and SHP-2 by PIR-B, one would predict that engagement of PIR-B with BCR dephosphorylates only PLC-g2 rather than many substrates. However, as shown in this study, not only PLC-g2 but also several signaling molecules ( Figure 4) were dephosphorylated by coligation of PIR-B and BCR. Furthermore, analyses of phosphotyrosine-containing proteins of whole cellular lysates indicate the inhibition of tyrosine phosphorylation of many proteins by PIR-B (data not shown). Thus, our data favor a model in which the activation of upstream PTKs rather than PLC-g2 itself are down-modulated by PIR-B ligation.
Among BCR-activated PTKs, Syk and Btk are particularly important, since genetic studies indicate the requirement of Syk and Btk for BCR-induced tyrosine phosphorylation of PLC-g2 (Fluckiger et al., 1998; Scharenberg et al., 1998; Takata and Kurosaki, 1996; Takata et al., 1994) . Indeed, BCR-induced activation of Syk and Btk was profoudly inhibited by coligation of PIR-B and BCR, and this inhibition was substantially recovered by overexpression of catalytically inactive SHP-1-C453S. As PIR-B-mediated inhibition requires redundant function of SHP-1 and SHP-2 (Maeda et al., 1998) , overexpression of SHP-1C-453S would likely block the function of both SHP-1 and SHP-2 to a similar extent. PIR-B-mediated dephosphorylation of Iga and Igb could also account for down-modulation of Syk, because tyrosine phosphorylation of Syk is followed by its association with phosphorylated Iga/Igb Kurosaki, 1997; Pleiman et al., 1994; Reth and Wienands, 1997) . In contrast to substantial restoration of Syk and Btk phosphorylation by SHP-1-C453S, less restoration of Iga/Igb phosphorylation suggests that PIR-Bmediated Iga/Igb dephosphorylation is mediated by another type of tyrosine phosphtase(s). Involvement of this phosphatase, in addition to SHP-1 and SHP-2, might explain the residual PIR-B inhibition in SHP-1 and SHP-2 double-de®cient DT40 cells (Maeda et al., 1998) . In contrast to Syk and Btk, Lyn activation was not signi®cantly inhibited by PIR-B ligation. Thus, our data indicate that among the three types of BCRactivated PTKs, Syk and Btk are speci®cally downmodulated by SHP-1 and SHP-2, thereby leading to inhibition of PLC-g2 phosphorylation.
In summary, our data support the following mechanism: (a) Coligation of PIR-B and BCR results in phosphorylation of PIR-B ITIMs by Lyn; (b) SHP-1 and SHP-2 are recruited to the phosphorylated PIR-B ITIMs via their SH2 domains, and are subsequently activated; (c) activated SHP-1/SHP-2 dephosphorylate their substrates apparently including Syk and Btk; (d) down-modulation of Syk and Btk by presumably dephosphorylation of tyrosine residues in their activation loop inhibits PLC-g2 activation; (e) downmodulated PLC-g2 decreases IP 3 generation, leading to a block of calcium mobilization.
Materials and methods

Cells, expression construct and Abs
Various mutant DT40 cells and A20 IIA1.6 cells were maintained in RPMI 1640 supplemented with 10% FCS, penicillin, streptomycin, and glutamine. For making FcgRIIB/PIR-B chimera, the cDNA of mouse FcgRIIB (corresponding to amino acid residue: 729 to 207 including signal peptide) and PIR-B (corresponding to amino acid residue: 641 ± 818) were fused by using PCR. Mutations that tyrosine residues at posistions 690, 719, 747, 771 and 801 to phenylalanine were introduced by the PCR method. Resulting constructs were con®rmed by DNA sequencing. The mutant and wild type FcgRIIB/ PIR-B cDNAs were subcloned into pApuro vector and were electroporated into DT40 or A20 IIA1.6 cells as described previously (Sugawara et al., 1997) . After selecting clones in the presence of puromycin (0.5 mg/ml), cell surface expression levels of FcgRIIB/PIR-B were checked by¯ow cytometry analysis using anti-mouse FcgRIIB mAb, 2.4G2 (Unkeless, 1979) . Anti-chicken IgM mAb M4, anti-Syk Ab, anti-PLC-g2 Ab, anti-SHP-1 Ab, anti-Iga Ab were already described (Maeda et al., 1998; Sanchez et al., 1993; Takata et al., 1994) . Anti-PIR-B Ab was obtained by immunizing rabbits with bacterially expressed glutathione S-transferase fusion protein containing PIR-B cytoplasmic region. Anti-SHP-2 Ab, intact rabbit anti-mouse IgM, F(ab') 2 rabbit anti-mouse IgM, intact rabbit anti-mouse IgG, F(ab') 2 rabbit anti-mouse IgG, and anti-phosphotyrosine mAb 4G10 were purchased from Santa Cruz Biotechnology Inc, Zymed laboratories Inc, Chemicon Inc, Chemicon Inc, and Upstate Biotechnology Inc, respectively. The anti-Btk mAb 43-3B was used for immunoprecipitation and Western blotting of Btk (Baba et al., in press ). Polyclonal anti-Lyn Ab used to immunoprecipitate was kindly provided by Drs H Umemori and T Yamamoto (Institute of Medical Science, University of Tokyo., unpublished data). Western blotting of Lyn was accomplished using the monoclonal anti-Lyn, Lyn 8 (Yamanashi et al., 1992) .
Vaccinia viruses
Recombinant vaccinia viruses encoding wild type and dominant-negative forms (cysteine 453 to serine) of SHP-1 have been described (Burshtyn et al., 1996) . For infections, A20 IIA1.6 cells (2610 6 cells/ml) were incubated in serum-free RPMI 1640 for 1 h at 378C at a multiplicity of infection of 20. Cells were then incubated for 3 h at 10 6 cells/ml in RPMI 1640 supplemented with 10% FCS.
Immunoprecipitation and Western blotting analysis
Cells were solubilized in lysis buer (1% NP-40, 150 mM NaCl, 20 mM Tris, pH 7.5, 1 mM EDTA, 10% glycerol) containing 50 mM NaF, 10 mM molybdate, 2 mM sodium vanadate supplemented with protease inhibitors as described previously (Sugawara et al., 1997) . For immunoprecipitation, precleared lysates were sequentially incubated with Abs and protein A-agarose or anti-rat IgGagarose. Lysates or immunoprecipitates were separated by SDS ± PAGE gel, transferred to nitrocellulose membrane, and detected by appropriate Abs and ECL system (Amersham Corp.). To examine in vitro kinase activity of Syk, immunoprecipitated Syk was suspended in kinase buer (20 mM Tris, pH 7.5, 10 mM MgCl 2 , 10 mM MnCl 2 ) in the presence of ATP (1 mM). Recombinant glutathione S-transferase fusion protein containing a cytoplasmic domain of mouse Iga (5 mg) was used as an exogenous substrate (Saouaf et al., 1994) . The reactions were allowed at 308C for 10 min and terminated by the addition of sample buer. The mixture was separated by SDS ± PAGE gel, transferred to nitrocellulose membrane, and detected by 4G10 and ECL system. For in vitro kinase assay of Lyn and Btk, immunoprecipitates were suspended in kinase buer (20 mM PIPES, pH 7.5, 20 mM MnCl 2 ) containing [g-32 P]ATP (43000 Ci/mmol, Amersham), 5 mg of enolase (Sigma) and incubated at 258C for 3 min. The reaction was stopped by addition of sample buer. The mixture was separated by SDS ± PAGE gel, followed by autoradiography.
Calcium and phosphoinositide analysis
For calcium analysis, cells (5610 6 ) were suspended in PBS containing 20 mM HEPES (pH 7.2), 5 mM glucose, 0.025% BSA and 1 mM CaCl 2 , and loaded with 3 mM Fura-2/AM at 378C for 45 min. Cells were washed twice, and adjusted to 10 6 cells/ml. Continuous monitoring of¯uorescence from the cell suspension was performed using Hitachi F2000¯uorescence spectrophotometer (Hitachi Limited, Tokyo, Japan) at an excitation wavelength of 340 nm and an emission wavelength of 510 nm. Calibration and calculation of calcium levels were done as described (Grynkiewicz et al., 1985) . For phosphoinositide analysis, cells (10 6 /ml) were labeled with myo-3 H-inositol (10 mCi/ml, 105 Ci/mmol, Amersham) for 5 ± 6 h in inositol-free RPMI-1640 supplemented with 10% dialyzed FCS, then stimulated with intact or F(ab') 2 fragment of rabbit antimouse IgG. The soluble inositol phosphates were extracted with trichloroacetic acid at indicated time points, and applied to AG 1-X8 (formate form) ion exchange columns (Bio-Rad Laboratories) pre-equilibrated with 0.1 M formic acid. The columns were washed with 10 ml water and 10 ml of 60 mM ammonium formate/5 mM sodium tetraborate. Elution was performed with increasing concentrations of ammonium formate (0.1 ± 0.7 M) (Berridge et al., 1983) .
Flow cytometric analysis for surface expression of FcgRIIB/PIR-B Cells were washed, stained with FITC-conjugated 2.4G2 (PharMingen) and analysed by FACScan (Becton-Dickinson & Co.). The x axes and y axes for the histograms in inserted boxes (Figure 1b) indicate¯uorescence intensity (4-decade-log scales) and relative cell number, respectively.
